Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles

A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death

I Hajimohammadreza, AW Probert, LL Coughenour, SA Borosky, FW Marcoux, PA Boxer and KK Wang
Journal of Neuroscience 1 May 1995, 15 (5) 4093-4101; DOI: https://doi.org/10.1523/JNEUROSCI.15-05-04093.1995
I Hajimohammadreza
Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AW Probert
Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LL Coughenour
Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SA Borosky
Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FW Marcoux
Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PA Boxer
Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KK Wang
Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/JNEUROSCI.15-05-04093.1995
PubMed 
7538570
Published By 
Society for Neuroscience
History 
  • First published May 1, 1995.
  • Version of record published May 1, 1995.
Copyright & Usage 
© 1995 by Society for Neuroscience

Author Information

  1. I Hajimohammadreza,
  2. AW Probert,
  3. LL Coughenour,
  4. SA Borosky,
  5. FW Marcoux,
  6. PA Boxer, and
  7. KK Wang
  1. Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.

Author contributions

Disclosures

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2023-12-10
to
E.g., 2023-12-10

Article usage: January 2018 to December 2023

AbstractFullPdf
Jan 2018903
Feb 2018702
Mar 2018504
Apr 2018803
May 20181008
Jun 20181104
Jul 2018405
Aug 20181104
Sep 20181204
Oct 2018403
Nov 2018706
Dec 20181105
Total 201899051
Jan 2019805
Feb 2019902
Mar 20191004
Apr 2019906
May 20191307
Jun 2019904
Jul 2019705
Aug 20197011
Oct 20191108
Nov 2019508
Dec 20195015
Total 201993075
Jan 2020505
Feb 20201308
Mar 2020206
May 2020403
Jun 2020609
Jul 2020603
Aug 2020101
Sep 2020905
Oct 20201407
Nov 20201006
Dec 20201306
Total 202083059
Jan 202115011
Feb 2021902
Mar 202111014
Apr 2021705
May 202117011
Jun 20211402
Jul 2021604
Aug 202111011
Sep 20211009
Oct 202114018
Nov 20217017
Dec 20211308
Total 20211340112
Jan 20221102
Feb 2022804
Mar 2022703
Apr 20221103
May 20229014
Jun 20221105
Jul 20221001
Aug 20221404
Sep 202213010
Oct 20221804
Nov 2022601
Dec 2022403
Total 2022122054
Jan 20233001
Feb 20231602
Mar 20231706
Apr 20231402
May 2023707
Jun 2023700
Jul 20231308
Aug 2023808
Sep 20231205
Oct 20231201
Nov 20231007
Dec 2023302
Total 2023149049
Total6800400
Back to top

In this issue

The Journal of Neuroscience: 15 (5)
Journal of Neuroscience
Vol. 15, Issue 5
1 May 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
View Full Page PDF
Citation Tools
A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death
I Hajimohammadreza, AW Probert, LL Coughenour, SA Borosky, FW Marcoux, PA Boxer, KK Wang
Journal of Neuroscience 1 May 1995, 15 (5) 4093-4101; DOI: 10.1523/JNEUROSCI.15-05-04093.1995

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death
I Hajimohammadreza, AW Probert, LL Coughenour, SA Borosky, FW Marcoux, PA Boxer, KK Wang
Journal of Neuroscience 1 May 1995, 15 (5) 4093-4101; DOI: 10.1523/JNEUROSCI.15-05-04093.1995
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.